Brief: Hofseth Biocare Q1 Revenue NOK 52 Million
16/05/2024 07:00
May 16 (Reuters) - Hofseth Biocare Q1 adjusted free cash flow NOK -19.5 million. * Q1 EBITDA NOK -16.2 million
Recent news on Hofseth Biocare ASA
See all newsBrief: Hofseth BioCare Board Member Buys 2.5 Mln Shares in Company
Brief: Hofseth Biocare Appoints Leif Arne Giske As CFO
Hofseth BioCare Q2 operating revenue slips on lower raw material volumes
Brief: Hofseth Biocare Q2 Revenue NOK 65.7 Million
Brief: Research Corporation Buys 14.3 Mln Shares In Hofseth Biocare